FDA Adverse Event Malfunction Summary report: N

BD ULTRA-FINE¿ INSULIN SYRINGE

MDR report key: 7948153 · Received October 9, 2018

Report

Report Number
1920898-2018-00768
Event Type
Malfunction
Date Received
October 9, 2018
Date of Event
September 17, 2018
Report Date
November 6, 2018
Manufacturer
BD MEDICAL - DIABETES CARE
Product Code
FMF
UDI-DI
00382903204403
PMA / PMN Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

CUSTOMER RETURNED (10) 3/10CC, 8MM, 31G SYRINGES IN AN OPEN POLY BAG WITH THE SHELF CARTON FROM LOT # 8043555. CUSTOMER STATES THAT THE NEEDLES ARE BENT AND HAVE SOME KIND OF RESIDUE ON SOME OF THEM. ALL RETURNED SYRINGES WERE EXAMINED AND NO BENT CANNULA WAS OBSERVED. HOWEVER, ONE SAMPLE EXHIBITED A HARD, CLEAR PIECE OF MATERIAL ON THE SURFACE OF THE CANNULA SHAFT. A SMALL PORTION OF THIS MATERIAL WAS REMOVED FROM THE SAMPLE AND PREPARED FOR FTIR SPECTRAL ANALYSIS. THE SPECTRAL ANALYSIS SHOWS THAT THIS MATERIAL IS MOST LIKELY ADHESIVE. (B)(4) WAS INITIATED BY THE HOLDREGE PLANT TO ADDRESS ADHESIVE RUNOVER. A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR BATCH# 8043555. ALL INSPECTIONS AND CHALLENGES WERE PERFORMED PER THE APPLICABLE OPERATIONS QC SPECIFICATIONS EXCEPT AS NOTED BELOW. THERE WAS ONE (1) NOTIFICATION [200743399] NOTED THAT DID NOT PERTAIN TO THE COMPLAINT. BASED ON THE SAMPLES/PHOTO(S) RECEIVED THE INVESTIGATION CONCLUDED: CONFIRMED: BD WAS ABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE (ADHESIVE ON CANNULA). UNCONFIRMED: BD WAS NOT ABLE TO DUPLICATE OR CONFIRM THE CUSTOMER¿S INDICATED FAILURE (BENT CANNULA). PROBABLE ROOT CAUSE DETERMINED TO BE MISALIGNMENT DURING APPLICATION OF ADHESIVE ON THE NEEDLE LINES. WHEN THIS OCCURS, ADHESIVE RUNOVER ONTO THE HUB OR POSSIBLE THE CANNULA MAY OCCUR. ADDITIONALLY, ADHESIVE MAY BE INACCURATELY APPLIED TO THE RUBBERIZED PULL WHEEL ON THE LINE, WHICH CAN ADDITIONALLY TRANSFER ADHESIVE TO THE CANNULA DURING ROUTINE USE.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD ULTRA-FINE INSULIN SYRINGES HAVE A RESIDUE ON THEM. THERE WAS NO REPORT OF EXPOSURE, SERIOUS INJURY OR MEDICAL INTERVENTION.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT BD ULTRA-FINE¿ INSULIN SYRINGES HAVE A RESIDUE ON THEM . THERE WAS NO REPORT OF EXPOSURE, SERIOUS INJURY OR MEDICAL INTERVENTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
786724 BD ULTRA-FINE¿ INSULIN SYRINGE INSULIN SYRINGE FMF BD MEDICAL - DIABETES CARE 8043555 00382903204403

Patients

Seq Age Sex Outcome Treatment
1 Other